Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity PAR-24-293 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.